Skip to main content
. 2018 May 18;126(5):057005. doi: 10.1289/EHP2387

Figure 3.

Figures 3A, 3B, 3C, and 3D are bar graphs plotting the change in F340/380 (y-axis) across E2, 4 prime OH BDE 049, 5 prime OH BDE 099, and 3 prime OH BDE 154, respectively, (x-axis) measured in control group, 0.1, 1, 10, 100, and 1000 nanomolar for E2, and measured in control group, 10, 100, 1000 and 10000 nanomolar for 4 prime OH BDE 049, 5 prime OH BDE 099, and 3 prime OH BDE 154. Inset each figure subpart are line graphs plotting the same across time in seconds. Figure 3E is a bar graph plotting the relative value of F340/380 (y-axis) across control group, E2, and 11 OH BDEs (x-axis) in the presence of 10 micromolar G15 and in the absence of G15.

Effects of 17β-estradiol (E2) and 11 hydroxylated polybrominated diphenyl ethers (OH-PBDEs) on calcium mobilization in SKBR3 cells and the inhibitory effects of G15. (AD) Calcium mobilization induced by different concentrations of E2, 4ʹ-OH-BDE-049, 5ʹ-OH-BDE-099, and 3ʹ-OH-BDE-154. The insets denote the change of F340/380 (the ratio of fluorescence intensity at 340nm and 380nm of calcium indicator fura-2-acetoxymethyl ester) with time, and the arrows indicate the time at which the compounds were added. (E) Calcium mobilization induced by 100nM E2 and 1μM OH-PBDEs in the absence or presence of 10μM G15, a G protein–coupled estrogen receptor antagonist. The relative value of F340/380 after (the average of the last three data points in the time course curve as shown in the insets of AD) and before adding the compounds is used to characterize the calcium mobilization. *p<0.05 compared with the control group (Ctrl, 0.1% dimethyl sulfoxide). #p<0.05 compared with the groups treated with compounds in the absence of G15.